Forward-Looking Statements Any statements made in this press release related to the development or commercialization of pemvidutide, an investigational product candidate, and other business, regulatory and financial matters including without limitation, clinical trial study design, status, correspondence, results and data, including related to the completed IMPACT trial, or the ongoing RECLAIM and RESTORE trials, the timing of key milestones for the Companys clinical programs, future plans or expectations for pemvidutide for the treatment of MASH, AUD and ALD, the potential benefits of Fast Track and Breakthrough Therapy Designations, including potential regulatory timeline and approval benefits, the Companys financial position, and the prospects for receiving regulatory approval or commercializing or selling any product or drug candidates, financial results, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
The new Wegovy pill, meanwhile, is approved for 25 mg daily
Weight, blood pressure, heart rate, and glycaemic parameters (if the patient has diabetes or prediabetes) should be reviewed at each dose escalation and then at least every three to six months once the maintenance dose is reached
Tell your healthcare provider about all the medicines you take including prescription and over the-counter medicines, vitamins, and herbal supplements
